Background {#Sec1}
==========

Particulate matter (PM) is a complex mixture of solid and liquid particles released into the environment during coal, petroleum, and fossil fuel combustion \[[@CR1]\]. PM with aerodynamic diameter ≤ 2.5 μm (PM~2.5~) is known to significantly contribute to airway inflammation \[[@CR2]--[@CR4]\]. Epidemiological studies have demonstrated that anthropogenic PM~2.5~ exposure was associated with the exacerbation of respiratory diseases, all-cause mortality, and cardiopulmonary mortality \[[@CR5]--[@CR7]\]. Low PM~2.5~ exposure levels also pose certain public health risks \[[@CR8]\].

Pneumococcus, a Gram-positive coccus, is the most common cause of global pneumonia mortality \[[@CR9]\]. Alveolar macrophages are mainly responsible for the pulmonary defense against pneumococcal infection \[[@CR10]\]. Activated macrophages release inflammatory mediators, including IL-1α/β, IL-6, TNF-α, IFN-α/β, CXCL10, MCP-1, and nitric oxide (NO), recruiting nearby immune cells against pneumococcal infection \[[@CR11]\]. Alveolar macrophage depletion increased mortality and lung bacterial burden \[[@CR12]\], indicating that macrophages play a crucial role in protective anti-inflammation in pneumococcal pneumonia.

Mounting evidence shows that exposure to ambient pollution particles impairs pulmonary functions and favors infectious diseases \[[@CR13]--[@CR15]\]. For instance, concentrated ambient particles enhance pneumococcus binding to macrophages, but decrease its internalization \[[@CR16]\]. Coal fly ash (CFA) impairs the antimicrobial peptide (AMP) function that increases *Pseudomonas aeruginosa* growth \[[@CR17]\]. Recently, CFA was demonstrated to adsorb to and complex with AMP, decreasing its antimicrobial activity \[[@CR18]\]. These lines of evidence indicate that ambient particles influence the airway immune defense, increasing bacterial infection susceptibility.

Ambient particles have been found in airway macrophages in the septum of healthy individuals \[[@CR19]\], and their impact on human immune responses have been reported \[[@CR15], [@CR18], [@CR20]\]. However, the pathophysiological relevance of PM~2.5~ exposure in the respiratory tract, particularly with respect to macrophages against bacterial infection, remains unclear. In this study, we aimed to investigate the effects of long-term PM~2.5~ exposure on macrophage activation against pneumococcal infection. We established a PM~2.5~-loaded murine model that was pneumococcus-infected to investigate macrophage functions and pulmonary pathogenesis. Further, molecular studies were performed to determine the effect of PM~2.5~ on signaling pathways and whether it acts as an immune suppressor in response to bacterial challenge, leading to the exacerbation of pneumococcus-induced lung pathogenesis.

Methods {#Sec2}
=======

Antibodies and reagents {#Sec3}
-----------------------

Antibodies against PI3K, p-Akt, t-Akt, p-p38, t-p38, p-JNK, t-JNK, p-Erk, t-Erk, and p-p65 were purchased from Cell Signaling Technology (Beverly, MA). Antibody specific to β-actin was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against inducible nitric oxide synthase (iNOS) and high mobility group box 1 (HMGB1) were purchased from Abcam (Cambridge, UK). Antibodies specific to t-p65 and CXCR3 were purchased from GeneTex (Irvine, CA) and Novus Biologicals (Centennial, CO), respectively. Inhibitors specific to Erk (PD98059), p38 (SB203580), JNK (SP600125), and NF-κB (JSH-23) were purchased from Sigma-Aldrich (St Louis, MO).

Cell and bacterial culture {#Sec4}
--------------------------

Macrophage cell line RAW264.7 (ATCC TIB-71) cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA) containing 10% complement-inactivated fetal bovine serum (HyClone, Logan, UT) and incubated at 37 °C in a humid atmosphere containing 5% CO~2~ \[[@CR21]\]. *Streptococcus pneumoniae* strain TIGR4 (virulent serotype 4, ATCC BAA-334) was cultured on blood agar plates (Becton Dickinson, Sparks, MD) and incubated at 37 °C under 5% CO~2~ \[[@CR22]\]. The bacteria were refreshed for 3 h in Todd Hewitt Broth (Becton Dickinson) to reach the logarithmic phase and were then used in the following infection experiments.

Characterization of particulate matter {#Sec5}
--------------------------------------

Particulate matter less than 2.5 μm diameter (PM~2.5~) (RM8785) was purchased from National Institute of Standards and Technology (MD, USA) \[[@CR23]\]. The particulate matter on filter media was fixed and coated with gold by an ion sputter (E-1010, Hitachi, Japan). The particle size was verified by field-emission scanning electron microscope (FE-SEM) (JSM 7500F, JEOL, Japan).

Cell viability assay {#Sec6}
--------------------

RAW264.7 cells (1 × 10^5^) were seeded in 96-well plates and treated with low (5 μg/ml) or high (20 μg/ml) doses of PM~2.5~ for 24 h. Cells were incubated with 0.5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution for 2 h. Formazan crystals were dissolved in isopropanol, and the absorbance at 570 nm was determined by a spectrophotometer (Bio-Rad, Hercules, CA) \[[@CR24]\]. The cell viability was expressed as a percentage compared to PM~2.5~-untreated group.

Phagocytosis assay {#Sec7}
------------------

The Phagocytosis Assay Kit (IgG FITC) (Cayman Chemical, Ann Arbor, MI) was employed to analyze whether PM~2.5~ affects the phagocytic activity of macrophages \[[@CR25]\]. RAW264.7 cells (2 × 10^6^) were treated with low (5 μg/ml) or high (20 μg/ml) doses of PM~2.5~ for 24 h. Latex beads coated with fluorescent-labeled rabbit IgG were incubated with cells at 37 °C for 3 h. The cells were fixed with 4% paraformaldehyde followed by staining with Hoechst 33342 (AAT Bioquest, Sunnyvale, CA). The signals of fluorescein isothiocyanate (FITC) and Hoechst 33342 were analyzed under a Laser Scanning Confocal Microscope (LSM780, Carl Zeiss, Germany).

Bacterial internalization assay {#Sec8}
-------------------------------

A gentamicin protection assay was used to analyze the bacterial internalization by macrophages \[[@CR26]\]. Briefly, RAW264.7 cells were treated with low (5 μg/ml) or high (20 μg/ml) doses of PM~2.5~ for 24 h prior to infection with pneumococcus (MOI = 10) for 6 h. The infected cells were treated with gentamicin (100 μg/ml) for 1.5 h to kill extracellular bacteria. The cells were lysed with sterilized water and cell lysates were seeded on blood agar plates by serial dilution. Visible colony-forming units (CFU) were calculated to determine the bacterial internalization activity.

Western blot assay {#Sec9}
------------------

RAW264.7 cells (2 × 10^6^) were untreated or treated with PM~2.5~ (20 μg/ml) for 24 h followed by infection with pneumococcus (MOI = 10) for an additional 6 h. Cells were washed and lysed with 100 μl RIPA containing protease and phosphatase inhibitors (Roche, Indianapolis, IN), and then subjected to western blot assay. The samples were resolved by 12% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA). The membranes were blocked by 5% skim milk and incubated with the primary antibodies followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies (Millipore). The proteins of interests were detected using ECL Western Blotting Detection Reagent (BIOMAN, Taipei, Taiwan) and analyzed by Azure C400 (Azure Biosystems, Dublin, CA) and AzureSpot Analysis Software (Azure Biosystems) \[[@CR27]\]. To determine the intensities of western blot bands, Un-Scan-It v6.1 software (Orem, UT, USA) was used. Identical areas surrounding each band were cropped, and protein expression levels were converted into pixel densities. Each area value was normalized to the β-actin density in the same lane on the gel, and then divided by the normalized density in the mock-control. Fold change represents protein expression level relative to the mock-control.

Analysis of nitric oxide production {#Sec10}
-----------------------------------

RAW264.7 cells (1 × 10^5^) were untreated or treated with 20 μg/ml PM~2.5~. After incubation for 24 h, the cells were infected with pneumococcus (MOI = 10) for 6 h. The culture medium was collected and the nitric oxide production was assessed by using Griess reagent (Sigma-Aldrich) \[[@CR28]\].

Quantitative real-time reverse transcription-PCR (qRT-PCR) {#Sec11}
----------------------------------------------------------

To explore the mRNA levels of iNOS, CD80, CD86, CD163, CD206, and F4/80 in macrophages, we performed qRT-PCR analysis in this study. The oligonucleotide primers for qRT-PCR quantification are shown in Table [S1](#MOESM1){ref-type="media"}. The mRNA levels were analyzed by qRT-PCR using SYBR Green I Master Mix and a model 7900 Sequence Detector System. The program was pre-incubated at 50 °C for 2 min and 95 °C for 10 min; PCR was performed with 35 cycles of 95 °C for 10 s and 60 °C for 1 min. The data for each gene quantity was determined by relative calculation using the 2^−ΔΔCt^ method. The method was used to calculate fold changes in each treatment group.

Determination of cytokine production {#Sec12}
------------------------------------

RAW264.7 cells were untreated or treated with 20 μg/ml PM~2.5~ for 24 h, the cells were uninfected or infected with pneumococcus (MOI = 10) for 6 h. The supernatant was collected from cell culture, and the expression levels of sHMGB1, IL-1α, IL-1β, TNF-α, CXCL9, CXCL10, and CXCL11 were analyzed using sandwich enzyme-linked immunosorbent assay (ELISA, R&D Systems, Minneapolis, MN) \[[@CR29]\].

Animal study {#Sec13}
------------

Male BALB/c mice (aged 6 weeks) were obtained from the National Laboratory Animal Center (Taipei, Taiwan). The mouse experiments were performed in accordance with the Animal Care and Use Guidelines for Chang Gung University under a protocol approved by the Institutional Animal Care Use Committee (IACUC Approval No.: CGU16--019). Mice were divided into four groups for the treatments with PBS (mock), PM~2.5~, pneumococcus, and PM~2.5~ + pneumococcus (10 mice per group; 6 mice for harvesting bronchoalveolar lavage fluid (BALF) and 4 mice for histopathological examination). PM~2.5~ was administered by intratracheal (i.t.) instillation twice per week for 3 weeks (total amount of PM~2.5~ = 200 μg). Amongst, two mice in PM~2.5~ + pneumococcus group died during PM~2.5~ exposure period and were excluded in the following studies. Mice were placed in the chambers, allowed to rest for 4 days, and then infected with pneumococcus by intranasal (i.n.) injection (1 × 10^8^ CFU/10 μl). After infection for 48 h, the mice were euthanized, and the BALF and lungs were isolated as described previously \[[@CR21]\]. Bacterial survival in BALF was analyzed. In each group, 6 mice were used to prepare BALF for cell enumeration and differentiation, while the lung tissues of 4 mice were investigated using H&E and IHC staining. qRT-PCR assay was employed to assess the copy number of pneumococcus genomic DNA in BALF. The oligonucleotide primers used to analyze pneumococcus TIGR 4 were as follows: forward, 5′-GGG GAA GTA TTT TCA GAG TCG-3′; and reverse, 5′-AAT CAC CAA CTA ACC ATC CAA TAG-3′ \[[@CR30]\]. The inflammatory cells in BALF were distinguished using Wright--Giemsa stain.

Cytokine array {#Sec14}
--------------

BALF prepared from each mouse in the same group were pooled into one sample and analyzed by Proteome Profiler Array (R&D Systems). Images were captured using an Azure C400 (Azure Biosystems, CA). The quantifications of each dot were measured by Image J, and the fold changes were calculated by Log~2~. The expression levels of cytokines were expressed as the average signal intensity of duplicate spots subtracted from signal background and normalized to total protein concentration.

Histopathological analysis {#Sec15}
--------------------------

Lung tissues isolated from mice were prepared for hematoxylin-eosin (H&E) or immunohistochemistry (IHC) staining as described previously \[[@CR31]\]. The lung sections were stained with antibodies against CXCR3, IL-1β, and F4/80, respectively, followed by incubation with HRP-conjugated secondary antibodies and developed with an ABC kit (Vector Laboratories, Burlingame, CA). The stained tissues were observed and evaluated by using a microscope (AXIO IMAGER M2, Carl Zeiss, Germany).

Statistical analysis {#Sec16}
--------------------

Statistical analysis was performed using the SPSS program (version 18.0 for windows, SPSS Inc., Chicago, IL), and all data are shown as mean ± standard deviation (SD). Statistical significance was determined by Student's *t*-test for two groups and one-way ANOVA with Tukey post-hoc test for more than two groups. *P-*value of less than 0.05 was considered statistically significant.

Results {#Sec17}
=======

PM~2.5~ impairs phagocytosis of pneumococcus by macrophages {#Sec18}
-----------------------------------------------------------

We first characterized particulate matter size using FE-SEM. The size distribution was dominated by particles smaller than 2.5 μm (referred to as PM~2.5~) (Fig. [1](#Fig1){ref-type="fig"}a). RAW264.7 cells were then treated with 20 μg/ml PM~2.5~ for 24 h, and light microscopy showed that the particulate matter was deposited and likely embedded in the cells (Additional file [1](#MOESM1){ref-type="media"}: Fig. S1). We further investigated the influence of PM~2.5~ exposure on macrophage viability by treating RAW264.7 cells with low (5 μg/ml) or high (20 μg/ml) PM~2.5~ doses for 24 h. Cell viability was minimally affected by both doses (Fig. [1](#Fig1){ref-type="fig"}b). Additionally, PM~2.5~ exposure only marginally influenced pneumococcal survival (Fig. [1](#Fig1){ref-type="fig"}c). Therefore, 5 and 20 μg/ml of PM~2.5~ were employed for subsequent experiments. Fig. 1PM~2.5~ does not affect macrophage viability and pneumococcus survival. **a** Transmission electron micrograph of the particulate matter. The magnified images of cropped areas are shown in the right panels. Original magnification: 3000× (upper panel) and 8000× (lower panel). Scale bars, 1 μm. **b** Cell viability of RAW264.7 cells exposed to low (5 μg/ml) or high (20 μg/ml) doses of PM~2.5~ for 24 h, analyzed with MTT assay. **c** Pneumococcus incubated with low or high PM~2.5~ doses for 6 h. Bacteria grown on the blood agar plates were counted and expressed as colony-forming units (CFU). Results are presented as mean ± standard deviation from triplicate independent experiments

To examine whether PM~2.5~ exposure affects macrophage phagocytic activity, we analyzed phagocytosis using antibody-coated latex beads and fluorescence. Low PM~2.5~ dose (5 μg/ml) slightly reduced macrophage internalization of the latex beads (Fig. [2](#Fig2){ref-type="fig"}a). In contrast, high PM~2.5~ dose (20 μg/ml) treatment dramatically reduced latex bead internalization, indicating that PM~2.5~ hinders macrophage phagocytic activity. We further determined bacterial internalization by macrophages using the gentamicin protection assay. As shown in Fig. [2](#Fig2){ref-type="fig"}b, the total bacterial survival was significantly increased in RAW264.7 cells treated with both low and high doses of PM~2.5~. These results indicate that PM~2.5~ exposure impairs macrophage phagocytic activity and may reduce pneumococcal clearance. Fig. 2PM~2.5~ suppresses macrophage phagocytosis in response to pneumococcal infection. **a** RAW264.7 cells were exposed to low (5 μg/ml) or high (20 μg/ml) doses of PM~2.5~ for 24 h, and then incubated with latex fluorescent beads for 3 h. The nuclei were stained with Hoechst 33342 and the image was analyzed by confocal microscopy. Scale bar, 10 μm. **b** RAW264.7 cells were exposed to low or high doses of PM~2.5~ for 24 h before pneumococcal infection for 6 h (MOI = 10). Intracellular pneumococcal survival was determined using gentamicin protection assays and expressed as viable CFU. Results are represented mean ± standard deviation from triplicate independent experiments and *P*-value was determined by using one-way ANOVA followed by a post-hoc test (\*, *P* \< 0.05)

PM~2.5~ inhibits macrophage pneumococcus-induced inflammatory mediators {#Sec19}
-----------------------------------------------------------------------

Nitric oxide (NO) generated by inducible nitric oxide synthase (iNOS) in macrophages is known to kill microorganisms \[[@CR32]\]. Therefore, the effects of PM~2.5~ on NO production and pneumococcal clearance by macrophages were investigated. Our results showed that iNOS expression was higher in both PM~2.5~-exposed and pneumococcus-infected cells than in untreated mock cells (Fig. [3](#Fig3){ref-type="fig"}a). In contrast, pneumococcus-induced iNOS expression was markedly reduced by PM~2.5~-treatment. In parallel, nitrite levels were increased in PM~2.5~-exposed or pneumococcus-infected cells, but significantly reduced in PM~2.5~-treated macrophages that were challenged with pneumococcus (Fig. [3](#Fig3){ref-type="fig"}b). These results indicate that PM~2.5~ inhibits pneumococcus-induced iNOS protein expression and reduces nitric oxide production, thereby attenuating macrophage bactericidal activity. Fig. 3PM~2.5~ dampens pneumococcus-induced inflammatory mediators in macrophages. RAW264.7 cells were unexposed or exposed to 20 μg/ml of PM~2.5~ for 24 h, followed by pneumococcus challenge for 6 h. **a** iNOS expression levels were determined using western blotting, and (**b**) the culture supernatant nitrite concentrations were determined using Griess reagent and normalized to cell viability. **c** HMGB1 expression levels were analyzed using western blotting. Relative protein expression levels were normalized to those in the mock-treated group and are indicated under each band. **d** Secreted HMGB1 (sHMGB1), (**e**) IL-1α, (**f**) IL-1β, and (**g**) TNF-α production in culture supernatant were determined using ELISA. The values were means ± standard deviations from triplicate independent experiments. Statistical significance was evaluated using Student's *t*-test or one-way ANOVA followed by a post-hoc test (\*, *P* \< 0.05)

To further investigate the effect of PM~2.5~ on the inflammatory response, we measured the production of several proinflammatory cytokines. HMGB1 exerts proinflammatory activities when released from macrophages \[[@CR33]\]. Pneumococcus-induced HMGB1 expression in cells was significantly decreased by PM~2.5~ exposure (Fig. [3](#Fig3){ref-type="fig"}c). The same trend was also observed for other macrophage-produced proinflammatory cytokines, including sHMGB1, IL-1α, IL-1β, and TNF-α, which were inhibited by the co-treatment of PM~2.5~ and pneumococcus (Fig. [3](#Fig3){ref-type="fig"}d-g). These results demonstrate that PM~2.5~ impedes pneumococcus-induced proinflammatory cytokine production and may attenuate the immune response to bacterial infection.

Long-term PM~2.5~ exposure subverts pneumococcal clearance in lungs and exacerbates pulmonary pathogenesis {#Sec20}
----------------------------------------------------------------------------------------------------------

To ascertain whether long-term PM~2.5~ exposure impairs the immune response and enhances the bacterial burden in host respiratory systems, we established sets of PM~2.5~-exposed murine models (Fig. [4](#Fig4){ref-type="fig"}a). Mice were divided into four groups: untreated mock, PM~2.5~-exposed, pneumococcus-infected, and PM~2.5~ + pneumococcus co-treated groups. Mice were exposed to PBS or PM~2.5~, twice weekly, for 3 weeks (for a total of 200 μg), followed by pneumococcal infection for 48 h. The body weights and temperatures of the mice were measured every 3 days, and were not observed to be different among the four groups (Additional file [1](#MOESM1){ref-type="media"}: Fig. S2). The mice were then euthanized, BALF was collected, and bacterial loads were determined. Pneumococcal loads and bacterial genomic DNA copy numbers were increased in the PM~2.5~ + pneumococcus co-treated group, compared with those in the only pneumococcus-infected group (Fig. [4](#Fig4){ref-type="fig"}b and c). The BALF cells were differentiated using Wright-Giemsa stain. Lymphocyte count was markedly decreased in PM~2.5~ + pneumococcus co-treated mice, compared with those in the other treatment groups (Additional file [1](#MOESM1){ref-type="media"}: Table S2). In contrast, eosinophil count was increased in both the PM~2.5~-exposed and PM~2.5~ + pneumococcus co-treated groups. Fig. 4Long-term PM~2.5~ exposure enhances pneumococcal load in the lung. **a** Mice were intratracheally (i.t.) administered PM~2.5~ twice weekly for three weeks (for a total of 200 μg), and were infected with pneumococcus (1 × 10^8^) via intranasal (i.n.) instillation. Mice were euthanized 48 h post-infection, and their BALF harvested for (**b**) bacterial load and (**c**) pneumococcal genomic DNA copy number determination. Horizontal lines indicate the mean value in each treatment group

Murine lung tissues were then subjected to H&E and IHC staining. Inflammatory cells were absent around the lung bronchi of untreated and pneumococcus-infected mice (Fig. [5](#Fig5){ref-type="fig"}). However, there was notable inflammatory cell infiltration around the bronchi of PM~2.5~-exposed mice. After pneumococcal infection, lung inflammation was noticeable with erythrocyte infiltration in the pulmonary parenchyma. When PM~2.5~-exposed mice were pneumococcus-challenged, immune cell infiltration around the bronchi and erythrocytes in the pulmonary parenchyma were obvious in the lung tissues. Therefore, long-term PM~2.5~ exposure favors bacterial infection of the lungs, which exacerbates inflammation and aggravates pulmonary pathogenesis. Fig. 5PM~2.5~ aggravates pneumococcus-induced pulmonary pathogenesis**.** Mice were administered PM~2.5~ and pneumococcus-infected as described in Fig. [4](#Fig4){ref-type="fig"}. After euthanizing the mice, lung sections were subjected to hematoxylin/eosin (H&E) staining (*n* = 4 per treatment group). The lower panel shows magnified images of the cropped areas. Images were observed under a microscope with 200× magnification. Scale bars, 100 μm

PM~2.5~ dampens pneumococcus-induced chemokine production {#Sec21}
---------------------------------------------------------

To evaluate the effect of PM~2.5~ exposure on chemokine production in mice, chemokines in BALF were analyzed with cytokine array. The expression levels of CXCL13, CXCL10, IL-1RA TIMP-1, CXCL11, CXCL12, CCL12, CCL2, CXCL1, IL-16, CXCL9, TNF-α, and CD54 decreased, whereas that of C5/C5a increased in the PM~2.5~ + pneumococcus co-treated mice compared with those in the pneumococcus-infected mice (Fig. [6](#Fig6){ref-type="fig"}a). The ligands, CXCL9, − 10, and − 11, binding to CXCR3 play crucial roles in immune cell activation \[[@CR34]\]. We next explored macrophage expression of CXCL9, − 10, and − 11. As expected, CXCL9, − 10, and − 11 secretions were significantly decreased with prior PM~2.5~ exposure, followed by bacterial challenge, compared with that with pneumococcal infection alone (Fig. [6](#Fig6){ref-type="fig"}b-d). In addition, IHC analysis showed decreased expression of IL-1β and CXCR3 in the lung tissues of PM~2.5~ + pneumococcus co-treated mice when compared to that in the untreated mice (Additional file [1](#MOESM1){ref-type="media"}: Fig. S3). These results suggest that PM~2.5~ exposure attenuates the pneumococcus-induced chemokine production. Fig. 6PM~2.5~ inhibits pneumococcus-induced chemokine production. **a** Mice were administered PM~2.5~ and infected with pneumococcus, as described in Fig. [4](#Fig4){ref-type="fig"}. After euthanizing the mice, the collected BALF collected from mice (*n* = 6) was pooled into one sample and subjected to cytokine array analysis. Chemokine expression was quantified using ImageJ. Log2 fold changes were calculated for the PM~2.5~ + pneumococcus co-treated and only pneumococcus-infected groups. RAW264.7 cells were incubated with or without 20 μg/ml PM~2.5~ for 24 h, and pneumococcus-infected or uninfected for 6 h. Culture supernatant was collected, and the concentrations of (**b**) CXCL9, (**c**) CXCL10, and (**d**) CXCL11 were determined using ELISA. Statistical significance was analyzed using one-way ANOVA followed by a post-hoc test (\*, *P* \< 0.05)

Because CXCR3-mediated inflammation is regulated by the PI3K/Akt and MAPK pathways \[[@CR35]\], we further analyzed the levels of particular molecules involved in CXCR3 signaling. Decreases in CXCL9, − 10, and − 11 levels reduced CXCR3 and PI3K/Akt expression in PM~2.5~ + pneumococcus co-treated macrophages, compared with that for pneumococcal infection alone (Fig. [7](#Fig7){ref-type="fig"}a). Furthermore, the phosphorylation of p38, JNK, and Erk was markedly decreased in PM~2.5~ + pneumococcus co-treated cells as opposed to that in pneumococcus-infected cells (Fig. [7](#Fig7){ref-type="fig"}b). In parallel, TLR4 expression and p65 phosphorylation noticeably declined in macrophages co-treated with PM~2.5~ + pneumococcus compared with those in the pneumococcus-infected group (Fig. [7](#Fig7){ref-type="fig"}c). Fig. 7PM~2.5~ impairs pneumococcus-induced chemokine production via the PI3K/Akt and MAPK pathways. RAW264.7 cells were exposed to PM~2.5~ (20 μg/ml) for 24 h, followed by pneumococcus infection for 6 h. Cell lysates were prepared and subjected to western blot analysis using antibodies against (**a**) CXCR3, PI3K, and Akt, (**b**) p38, JNK, Erk, and their respective phosphorylated forms, and (**c**) TLR4, p65, and phosphorylated p65. β-actin was used as a loading control. Relative expression levels were normalized to those in the mock-treated group and are indicated under each band

We then conducted an inhibition assay to analyze the involvement of the MAPK and NF-κB signaling pathways in the macrophage function-impairing effect of PM~2.5~. Macrophages were pretreated with Erk inhibitor (PD98059), which was followed by PM~2.5~ and pneumococcus treatment. As shown in Fig. [8](#Fig8){ref-type="fig"}a, PM~2.5~ exposure decreased the level of phosphorylated Erk and the expression of iNOS, HMGB1, and CXCR3 in pneumococcus-infected macrophages. In parallel, pneumococcus-induced iNOS, HMGB1, p-Erk, and CXCR3 were significantly suppressed in cells pretreated with PD98059. Interestingly, the suppressive effect of PM~2.5~ on pneumococcus-induced inflammatory molecules was augmented by PD98059. This trend was also observed during the analysis of NO production and HMGB1 secretion (Fig. [8](#Fig8){ref-type="fig"}b-c). Our data further showed that pneumococcus-induced NO production was inhibited by PM~2.5~, SB203580 (p38 inhibitor), or SP600125 (JNK inhibitor) (Additional file [1](#MOESM1){ref-type="media"}: Fig. S4). Moreover, our findings suggest that pneumococcus-induced NO production can effectively be suppressed by co-treatment with PM~2.5~ and JSH-23 (NF-κB inhibitor). These results demonstrate that PM~2.5~ inhibits pneumococcus-stimulated macrophage activation through the MAPK and NF-κB signaling pathways. Fig. 8Signaling pathways involved in the inhibition of pneumococcus-induced chemokine production by PM~2.5~**.** RAW264.7 cells were pretreated with 20 μM PD98059 (Erk inhibitor) and exposed to PM~2.5~ (20 μg/ml) for 24 h, followed by pneumococcus infection (MOI = 10) for 6 h. Cell lysates were prepared and analyzed by western blotting using antibodies against (**a**) iNOS, HMGB1, p-Erk, t-Erk, and CXCR3. β-actin was used as a loading control. Relative expression levels were normalized to those in the mock-treated group and are indicated under each band. **b** nitric oxide concentrations were determined using Griess reagent, and (**c**) sHMGB1 production was assessed by ELISA. The data are means ± standard deviations from triplicate independent experiments. Statistical significance was evaluated using one-way ANOVA, followed by a post-hoc test (\*, *P* \< 0.05)

Discussion {#Sec22}
==========

Air pollution has become a serious public health concern worldwide. PM~2.5~ has a larger surface and can adhere to transient metals, toxic substances, and pathogens, and can be inhaled into the respiratory system \[[@CR36]--[@CR38]\]. A growing number of investigations have indicated that PM~2.5~ exposure is associated with several respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma \[[@CR39], [@CR40]\]. Noticeably, PM~2.5~ can penetrate the respiratory barrier and enter the circulatory system, therefore spreading throughout the body, leading to cardiovascular diseases, hypertension, diabetes mellitus, and systemic inflammation \[[@CR2], [@CR41]--[@CR44]\]. Alveolar macrophages initially engulf lung-deposited PM~2.5~ \[[@CR19]\] that impair the pulmonary immune system, resulting in increased bacterial infectivity \[[@CR17], [@CR18]\]. Given the evidence that PM~2.5~ poses adverse health risks, the current study comprehensively explored the mechanism underlying the PM~2.5~-mediated impairment of the primary immune defense against bacterial infection.

Phagocytosis is a strategy by which macrophages trigger lysosomes to degrade internalized bacteria \[[@CR45]\]. The activated macrophages then produce proinflammatory cytokines to recruit other immune cells associated with adaptive immunity, to collaboratively eradicate the pathogens \[[@CR46]\]. Concentrated ambient particles have been shown to inhibit macrophage bacteria internalization \[[@CR16]\]. Oil fly ash exposure damaged the lungs and decreased nitric oxide production, attenuating bacterial clearance by macrophages \[[@CR47]\]. Consistent with previous findings, our current results demonstrated that PM~2.5~ subverts macrophage phagocytic activity, and decreases proinflammatory cytokine production in response to pneumococcal infection. Furthermore, the nitric oxide level, which exhibits antimicrobial activity, was suppressed by PM~2.5~-mediated inhibition of iNOS expression. Collectively, these findings provide information on how particulate matter subverts macrophage activity to enhance bacterial infectivity.

High PM~2.5~ exposure levels (≥ 100 μg/ml) are known to enhance proinflammatory cytokine production, resulting in lung toxicity \[[@CR48]--[@CR50]\]. However, in this study, cell viability was unaffected and proinflammatory cytokine production was not significantly increased in macrophages treated with relatively low PM~2.5~ levels (20 μg/ml). In contrast, pneumococcal infection markedly enhanced proinflammatory cytokine secretion; however, this trend was in turn remarkably reduced by PM~2.5~ exposure. The low dose of PM~2.5~ administered to macrophages before pneumococcal challenge may have substantially suppressed proinflammatory cytokine production rather than being cytotoxic. The association between PM~2.5~ exposure at different concentrations and impaired macrophage function following pneumococcal infection merits further investigation.

It has been reported that PM induces inflammatory response through the TLR2 and TLR4 pathways \[[@CR51], [@CR52]\]. TLR2 recognizes pneumococcal peptidoglycan and induces an inflammatory response, thus promoting host defense against bacterial infection \[[@CR53]\]. In addition, macrophages infected with pneumococcus express a scavenger receptor, macrophage receptor with collagenous structure (MARCO), which is co-expressed with TLR2 and nucleotide-binding oligomerization domain-containing 2 (NOD-2), to regulate inflammatory responses \[[@CR54]\]. Further, another macrophage scavenger receptor, SR-AI/II has been reported to be implicated in innate defense against bacteria and TiO~2~ particles \[[@CR55]\]. Collectively, these findings indicate that pattern recognition receptors (PRPs) may act as receptors for bacteria and environmental particles. However, very few studies have assessed the synergistic and antagonistic interactions between PM and bacteria. Therefore, the extent to which bacteria and PM activate different, same, or opposing receptors is still unclear and warrants future studies.

HMGB1 is one of the danger-associated molecular pattern (DAMP) proteins, which are endogenous danger signals \[[@CR56]\]. HMGB1 is a ubiquitous nuclear protein facilitating NF-κB transcription in eukaryotes \[[@CR57]\]. Once HMGB1 is released by necrotic or activated immune cells, it activates the production of extracellular proinflammatory cytokines, including IL-1α, IL-1β, IL-6, IL-8, TNF-α, and IFN-γ \[[@CR58]--[@CR60]\]. Our results showed that HMGB1 production was increased by PM~2.5~-exposure or bacterial infection but decreased by PM~2.5~ + pneumococcus co-treatment. A similar trend was also observed for the expression level of phosphorylated p65. PM~2.5~-treatment plus bacterial infection inhibited the production of proinflammatory cytokines including IL-1α, IL-1β, and TNF-α, thereby enhancing bacterial infectivity. HMGB1 appears to significantly manipulate macrophage proinflammatory cytokine production during bacterial infection. However, the mechanism underlying PM~2.5~ suppression of HMGB1-mediated immune defense against pneumococcus remains to be elucidated.

Macrophages can be polarized into two phenotypes: M1 (proinflammatory phenotype) and M2 (anti-inflammatory phenotype) \[[@CR61]\]. Previous studies indicated that PM~2.5~ exposure significantly induced the inflammatory M1 polarization, which contributed to lung disorders \[[@CR62], [@CR63]\]. In contrast, recent investigations demonstrated that PM~2.5~ activated M2-polarization to exacerbate lung eosinophilia and allergic responses \[[@CR64], [@CR65]\]. However, discrepancies and controversial results have emerged. We, therefor, conducted additional studies to assess the effects of PM~2.5~ on macrophage phenotypic transition. The obtained ELISA and qRT-PCR results demonstrated that pneumococcal infection activated M1 macrophages (Fig. [3](#Fig3){ref-type="fig"}f-g and Additional file [1](#MOESM1){ref-type="media"}: Fig. S5A-C), which is in accordance with the results of previous studies \[[@CR66], [@CR67]\]. Noticeably, PM~2.5~ suppressed pneumococcus-induced M1 macrophage markers. In addition, IHC analysis showed that F4/80^+^ cells were increased in mice infected with pneumococcus when compared with mice in mock-control group (Additional file [1](#MOESM1){ref-type="media"}: Fig. S5F-G). Therefore, these findings indicate that PM~2.5~ manipulates macrophage polarization that is possibly responsible for the observed macrophage dysfunction, and it may impair the elimination of bacterial infection, thereby exacerbating inflammation.

The CXCR3 ligands, including CXCL9, − 10, and − 11, generate Th1 response \[[@CR34]\]. CXCL10/CXCR3 interaction is essential for promoting immune cell functions, including differentiation, migration, and activation \[[@CR34]\]. Activation of the macrophage CXCL10/CXCR3 axis is regulated by the PI3K/Akt and MAPK pathways \[[@CR68]\]. Additionally, CXCL10 production is positively associated with pneumococcal load \[[@CR69]\]. Our results expanded the prior findings and showed that CXCL9, − 10, and − 11 expression in BALF was significantly increased after pneumococcal infection, but decreased upon PM~2.5~ treatment. Furthermore, we identified that pneumococcus-induced CXCL10/CXCR3, MAPK, and NF-κB signaling pathway activation was suppressed by PM~2.5~ (Fig. [9](#Fig9){ref-type="fig"}). Impaired CXCL10 expression increases the susceptibility to bacterial infection \[[@CR70]\]. These findings support our results that PM~2.5~ decreases CXCL10/CXCR3 activation, thus contributing to pneumococcus-induced pathogenesis. Fig. 9Schematic model illustrating the mechanism underlying the PM~2.5~-mediated dampening of pneumococcus-induced macrophage activation and pulmonary infection exacerbation**.** PM~2.5~ exposure suppresses macrophage phagocytic activity and nitric oxide production during pneumococcal infection. Further, PM~2.5~ subverted proinflammatory cytokines and chemokines by inhibiting the PI3K/Akt and MAPK pathways in pneumococcus-infected macrophages

Pneumococcus is one of the most crucial human pathogens causing community-acquired pneumonia \[[@CR71]\]. The serotypes 1, 4, 6B, 7F, 14, and 19F of pneumococcal isolates are known to have an invasive disease potential in humans \[[@CR72]\]. The pneumococcal strain, serotype 4 (TIGR4) causes the most-severe invasive disease, while the serotype 1 clones cause low-level bacteremia without any disease symptoms \[[@CR73]\]. In addition, the completely sequenced genome of the TIGR4 strain has been extensively employed in laboratory animal models to elucidate the pathological features of pneumococcal pneumonia and sepsis \[[@CR74]\]. Therefore, due to its high virulence and poor pathogenic outcomes, we chose the TIGR4 strain for this study.

Although the mechanisms underlying the PM~2.5~-mediated dampening of macrophage activity against pneumococcal infection were investigated in this study, the cell-based and animal studies may not completely reflect the pathophysiology in humans. Moreover, it is difficult to collect BALF from PM~2.5~-exposed pneumococcal-infected patients. Further investigations should analyze samples from pneumococcus-infected patients living in PM~2.5~-polluted urban areas to fill the gap for the translational utility of the present study.

Conclusions {#Sec23}
===========

In the present study, we provided evidence that PM~2.5~ exposure impairs macrophage functions, including phagocytosis and nitric oxide production, which, in turn, hampers bacterial clearance activity. Additionally, PM~2.5~ perturbs the macrophage polarization and may cause macrophage dysfunction. Animal studies showed that long-term PM~2.5~-exposure inhibits pneumococcus-induced production of proinflammatory cytokines, favors pneumococcal infection, and exacerbates pulmonary pathogenesis. We further demonstrated that PM~2.5~ exposure dampens pneumococcus-induced chemokine and CXCR3 production through suppression of the PI3K/Akt and MAPK signaling pathways. Our findings provide novel translational insight into the mechanism underlying PM~2.5~-induced aggravation of pneumococcal infection of the airways.
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**Additional file 1: Figure S1.** Deposition of particulate matter in the cytoplasm. RAW264.7 cells were (A) untreated (mock) or (B) treated with 20 μg/ml PM~2.5~ for 24 h and subjected to light microscopic analysis. Arrows represent macrophages with phagocytosed PM~2.5~. Scale bars, 5 μm. **Figure S2.** The body weight and temperature of mice during the experiment. Mice were divided into four groups (10 per group) for the treatments with PBS (mock), PM~2.5~, pneumococcus (Sp), and PM~2.5~ + pneumococcus, respectively. The body weights and temperatures of the mice were measured every three days during the experiment. **Figure S3.** Long-term PM~2.5~-exposure decreases the expression of CXCR3 and IL-1β in pneumococcus-infected lung tissues. Mice were administered PM~2.5~ and pneumococcus-infected as described in Fig. [4](#Fig4){ref-type="fig"}. Mice were euthanized and lung tissues were subjected to immunohistochemical (IHC) staining with specific antibody against CXCR3 and IL-1β (original magnification: 200×). Magnified images of each cropped area are shown in the lower panel. Scale bars, 100 μm. **Figure S4.** Involvement of the MAPK and NF-κB signaling pathways in the suppression of pneumococcus-induced nitric oxide production by PM~2.5~. RAW264.7 cells were pretreated with SB203580 (10 μM), SP000125 (10 μM), or JSH-23 (20 μM) for 1 h, and exposed to PM~2.5~ (20 μg/ml) for 24 h, followed by pneumococcal infection for 6 h. The nitric oxide concentration was determined using Griess reagent. Statistical significance was evaluated using one-way ANOVA followed by a post-hoc test (\*, *P* \< 0.05) to compare with pneumococcus infection alone group. **Figure S5.** PM~2.5~ subverts the macrophage polarization**.** RAW264.7 cells were unexposed or exposed to 20 μg/ml of PM~2.5~ for 24 h, followed by pneumococcal challenge for 6 h. mRNA levels of (A) iNOS, (B) CD80, (C) CD86, (D) CD163, (E) CD206, and (F) F4/80 in macrophages were determined by qRT-PCR analysis. Data are presented as means ± standard deviations from triplicate independent experiments. Statistical significance was analyzed using one-way ANOVA, followed by a post-hoc test (\*, *P* \< 0.05). (G) Mouse lung tissues were subjected to immunohistochemical (IHC) and stained with anti-F4/80 antibody (original magnification: 200×). Magnified images of each cropped area are shown in the lower panel. Arrows in red indicated F4/80-positive cells. Scale bars, 100 μm. **Table S1.** Primers used for qRT-PCR. **Table S2.** Differentiated cell counts in BALF.
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